Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico / CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / FundaÃÃo Cearense de Apoio ao Desenvolvimento Cientifico e TecnolÃgico / As reaÃÃes alÃrgicas a fÃrmacos representam um terÃo das reaÃÃes adversas a medicamentos, e embora sejam pouco freqÃentes, apresentam altas taxas de morbidade e mortalidade, revelando um importante problema de saÃde pÃblica. Os principais desafios relacionados com a hipersensibilidade a fÃrmacos decorrem do fato de sua imprevisibilidade, de que nÃo existe um modelo animal para pesquisa e devido à variabilidade individual no que diz respeito ao metabolismo do fÃrmaco. As reaÃÃes alÃrgicas a medicamentos sÃo difÃceis de serem diagnosticadas, uma vez que hà carÃncia de mÃtodos laboratoriais para sua investigaÃÃo. O presente estudo teve como objetivo estabelecer alguns mÃtodos imunolÃgicos in vitro para o diagnÃstico de alergia a medicamentos. Vinte pacientes atendidos no AmbulatÃrio de Dermatologia do Hospital UniversitÃrio Walter CantÃdio, Universidade Federal do CearÃ, com manifestaÃÃes muco-cutÃneas e sistÃmicas decorrentes de hipersensibilidade a fÃrmacos foram investigados atravÃs de histÃria clÃnica, exames laboratoriais in vivo e in vitro. Foram avaliados os marcadores de ativaÃÃo de linfÃcitos CD25 e CD69 atravÃs de citometria de fluxo, em cÃlulas mononucleares do sangue perifÃrico previamente incubadas com diferentes concentraÃÃes do fÃrmaco suspeito, e anÃlise das citocinas interferon γ e interleucina 5 no sobrenadante da cultura atravÃs de teste imunoenzimÃtico. Dezoito pacientes foram submetidos aos testes cutÃneos, sendo que nove mostraram resultados positivos a um ou mais fÃrmacos. Quinze pacientes apresentaram positividade para pelo menos um dos marcadores de ativaÃÃo em resposta ao fÃrmaco suspeito. Os marcadores CD69 e/ou CD25 foram expressos pelas cÃlulas T CD4+ e CD8+, tanto em reaÃÃes imediatas como nas nÃo imediatas. A comparaÃÃo dos Ãndices de estimulaÃÃo desses marcadores entre pacientes e indivÃduos saudÃveis nÃo alÃrgicos, resultou em diferenÃa significativa para CD4+CD69+ nas trÃs concentraÃÃes do fÃrmaco suspeito e para CD4+CD25+ apenas na menor concentraÃÃo do fÃrmaco suspeito. Nenhuma diferenÃa significativa para as citocinas IFN-γ e IL-5 foi observada entre os pacientes e os indivÃduos controles. A detecÃÃo de ambos os marcadores de ativaÃÃo CD69 e CD25 aumentou a sensibilidade diagnÃstica do teste. O uso combinado dos marcadores representa uma ferramenta promissora no diagnÃstico laboratorial das reaÃÃes alÃrgicas a medicamentos. NÃo obstante, essa hipÃtese deve ser confirmada com um nÃmero maior de pacientes e controles. / Drug allergy reactions represent one third of adverse drug reactions, and although they are infrequent, they present high rates of morbidity and mortality, revealing a major public health problem. The main challenges related to drug hypersensitivity result from its unpredictability, no animal model for research and individual variability with regard to drug metabolism. Drug allergy reactions are difficult to be diagnosed once there is a lack of laboratorial tests for their investigation. The present study aimed to establish some immunological in vitro methods for diagnosing drug allergy. Patients (n=20) attending a dermatology outpatient clinic, Hospital Universitario Walter CantÃdio, Universidade Federal Ceara, with mucocutaneous and systemic manifestations due to drug hypersensitivity were investigated by clinical history, laboratory findings, and in vivo and in vitro tests. The lymphocyte activation markers, CD25 and CD69, were evaluated by flow cytometry on the peripheral blood mononuclear cells previously incubated with different concentrations of the suspected drug, and analysis of interferon γ and interleukin 5 was done in the culture supernatant by enzyme immunoassay. Eighteen patients were tested by skin tests; nine patients showed positive results to one or more drugs. Fifteen patients showed positivity for at least one of activation markers in response to the suspected drug. The markers CD69 and/or CD25 were expressed by T cells CD4+ and CD8+, both in immediate and delayed reactions. Comparing stimulation index of the markers between patients and healthy no allergic individuals, it was observed a significant difference for CD4+CD69+ in the three suspected drug concentrations and CD4+CD25+ only in the lower drug concentration. No significant differences were found for the cytokines IFN-γ and IL-5 between patients and healthy individuals. The detection of both activation markers CD69 and CD25 increased the diagnostic sensitivity of the test. The use of both markers represents a promising tool in drug allergy diagnosis. Nonetheless, this hypothesis needs to be confirmed with a greater number of patients and controls.

La synapse immunologique est une structure qui se forme à l’interface entre un lymphocyte T et une cellule présentatrice d’antigène lors de la reconnaissant d’un antigène étranger spécifique. Cette plate‑forme est actuellement considérée comme le lieu d’où est déclenchée la cascade de signalisation moléculaire conduisant à l’activation lymphocytaire. Les travaux présentés dans ce manuscrit décrivent un autre pôle de signalisation localisé sur le lymphocyte T, à l’opposé de la zone de contact. Ce pôle a été nommé antisynapse. On peut détecter cette structure dans la première minute avant le contact, avant l’apparition de la synapse immunologique. Elle contient les composants classiquement décrit à la synapse immunologique. Sa formation est indépendante de la reconnaissance d’antigène et déclenchée par l’adhésion entre les cellules. Plusieurs fonctions potentielles sont étudiés, l’antisynapse agit notamment comme un réservoir de molécules qui sont transférées à la synapse immune de manière dépendante des microtubules. L’antisynapse peut également être considérée comment une pre-synapse déclenchée avant la reconnaissance d’antigène. / The immunological synapse forms at the interface between a T cell and an antigen-presenting cell after foreign antigen recognition. The immunological synapse is considered to be the site where the signaling cascade leading to T lymphocyte activation is triggered. In this manuscript, we show that another signaling region can be detected before formation of the synapse at the opposite pole of the T cell. This pole has been named antisynapse. This structure appears during the first minute after the contact forms, is transient and contains all the classic components that have been previously described at the immunological synapse. Its formation is independent of antigen recognition but is driven by adhesion itself. Some potentials functions à discussed here, it constitutes a reservoir of signaling molecules that are potentially ready to be sent to the immunological synapse through a microtubule-dependent pathway. The antisynapse can thus be considered as a pre-synapse that is triggered independently of antigen recognition.

Modulation de la réponse lymphocytaire T par IL4I1 - RESUME : L’enzyme Interleukin-four Induced Gene 1 (IL4I1), qui dégrade la phénylalanine, est exprimée par des cellules présentatrices d’antigène (CPA) en réponse à des stimuli pro-inflammatoires. Elle affecte la prolifération et les fonctions lymphocytaires T et pourrait donc participer au rétrocontrôle des réponses immunitaires. Cependant, les mécanismes d’action d’IL4I1 restent encore mal connus. Mon projet de thèse a comporté deux axes. Dans un premier axe, j’ai participé à la caractérisation du rôle d’IL4I1 dans la différenciation des lymphocytes T CD4+ naïfs en lymphocytes T régulateurs et T auxiliaires effecteurs. Dans mon deuxième axe, qui représente la majeure partie de mon travail, j’ai analysé l’action d’IL4I1 sur les évènements précoces de l’activation T. J’ai observé qu’IL4I1 inhibe la phosphorylation de ZAP70 dès les premières minutes d’activation. Ce défaut se propage aux trois voies de signalisation principales : la voie calcique, la voie des MAP kinases et la voie NFκB. Elle retentit secondairement sur la capacité à former des synapses avec les CPA, ainsi que sur l’expression de différents marqueurs membranaires d’activation. L’activité enzymatique d'IL4I1 n’est pas responsable du défaut d’activation observé. L’étude des synapses CPA-T a montré une polarisation des vésicules de sécrétion contenant IL4I1 en direction de la cellule T ainsi qu’occasionnellement leur présence au contact du lymphocyte T. Des expériences complémentaires confirment la fixation d’IL4I1 sur les lymphocytes T. Ces données suggèrent un nouveau mécanisme d’action d’IL4I1 dépendant de sa liaison à un récepteur membranaire de la cellule T. - Mots clefs : Interleukin-4 induced gene 1 (IL4I1), enzyme immunosuppressive, signalisation du lymphocyte T / Modulation of the T cell response by IL4I1 - SUMMARY: The enzyme Interleukin-four Induced Gene 1 (IL41I), which degrades phenylalanine, is expressed by antigen presenting cells (APC) in response to pro-inflammatory stimuli. IL4I1 modifies the proliferation and function of T lymphocytes, and may participate in the negative feedback of the immune response. Its mechanism of action remains poorly understood.My thesis project included two tasks. In the first task, I participated in the characterisation of the role of IL4I1 in naive CD4+ T cell differentiation into regulatory and helper T lymphocytes. In the second task, and the main part of my thesis, I have studied the effect of IL4I1 on early T cell activation. I observed that ZAP70 phosphorylation was rapidly decreased after TCR stimulation. This alteration was transmitted to the three main downstream signalling pathways: calcium fluxes, the MAP kinase pathway, and the NFκB pathway. The enzymatic activity of IL4I1 was not responsible for the observed decreased activation. Analysis of the APC-T cell synapse showed the polarised secretion of IL4I1 toward the T cell. Labelling of IL4I1 was sometimes detected directly on T lymphocytes. Complementary experiments indicate that IL4I1 binds to T lymphocytes. These data suggest a new mechanism of action of IL4I1 dependent on its ability to bind a membrane receptor on T lymphocytes. - Key-words: Interleukin-4 induced gene 1 (IL4I1), Immunosuppressive Enzyme, T lymphocyte signalling.

This dissertation was intended to identify potential roles for phosphatidylinositol-3 kinase (PI-3 kinase) in the responses of lymphocytes to activation. To understand what functions PI-3 kinase is performing in lymphocytes, experiments were performed to identify proteins that will stably associate with the p85 subunit of PI-3 kinase. Co-precipitation revealed an activation dependent association of p85 with two different phosphotyrosine containing proteins. One protein, pp36-38, is a membrane protein that interacts with PI-3 kinase, PLCγ1, and Grb2/S0S. The other associated protein was identified as the proto-oncogene c-Cbl. The interaction of p85 with cbl was shown to be mediated through the SH2 domains of p85. More importantly, the interactions of p85 with p36-38 and cbl were found to be specific for p85 isoforms. Although the SH2 domains of the α and β isoforms are highly similar in amino acid sequence, they are shown to establish distinct protein interactions in intact cells. Experiments on the cbl/PI-3 kinase complex revealed a stimulation dependent translocation into membrane and insoluble/cytoskeletal fractions of wild type, but not mutant cells. The movement of cbl did not require tyrosine phosphorylation or PI-3 kinase activity. The cbl/PI-3 kinase complex was greatly enhanced in the membrane fraction in contrast to the cytosol, where the largest concentration of cbl can be found. In addition, these complexes were found to form at the membrane in the absence of the tyrosine kinase, p56lck.

T and B-lymphocytes play an important role in an adaptive immune response. Communication between these two cells may result in either a humoral immune response or tolerance. Communication between T and B-lymphocytes involves a number of inducible cell surface molecules on both T and B-lymphocytes. It was the aim of this project to gain a greater understanding of the role of CD40 in the dynamic communication that occurs between naïve T-lymphocytes and resting B-lymphocytes during cognate communication. Because in vivo antigen specific T-lymphocytes are at low frequency, it is difficult to examine antigen-specific naïve T-lymphocytes. Thus, an in vitro system employing naïve antigen-specific T cell receptor (TCR) transgenic T cells and small resting B-lymphocytes that did not express CD40 was devised to examine the role of CD40 in cognate communication between naïve T-lymphocytes and resting B-lymphocytes. Upon recognition of antigen on resting B-lymphocytes that expressed CD40, T-lymphocytes proliferated, expressed the activation antigens CD69 and CD25, and remained responsive to subsequent antigen challenge. In the absence of CD40, resting B-lymphocytes did not induce sustained proliferation or sustained expression of the activation markers CD69 and CD25 on naïve T-lymphocytes, and their recovery was decreased compared to naïve T-lymphocytes that recognized antigen on resting B-lymphocytes that expressed CD40. Naïve T-lymphocytes, however, remained responsive to subsequent antigen challenge after recognition of antigen on resting CD40-/- B-lymphocytes. Recognition of antigen on resting CD40-/- B-lymphocytes also resulted in increased recovery and antigen responsiveness of T-lymphocytes when compared to controls without antigen, The role of CD40 in sustaining activation of naïve T-lymphocytes may be unique to resting B-lymphocytes, since proliferation of naïve T-lymphocytes in response to dendritic cells that did not express CD40 was similar to proliferation of naïve T-lymphocytes in response to dendritic cells that expressed CD40. The mechanism by which CD40 sustained activation of naïve T-lymphocytes was investigated by examining the induction of various costimulatory molecules on resting CD40+/- and CD40-/- B-lymphocytes during cognate interaction with naive T-lymphocytes. Induction of B7-1, upregulation of CD44 and ICAM-1, and sustained but not initial induction of B7-2 required that CD40 be expressed on resting B-lymphocytes. Expression of B7-1 and CD44H was not required for proliferation of naïve T-lymphocytes in response to antigen presented on resting B-lymphocytes. However, sustained expression of B7-2 was crucial for proliferation of naïve T-lymphocytes in response to antigen presented on resting B-lymphocytes.

No description available.

Une réponse immunitaire efficace contre un large spectre de pathogènes ou contre des cellules tumorales nécessite l’activation des lymphocytes T CD4+. L’engagement du récepteur T par un peptide antigénique apprêté sur les produits de classe-II du complexe majeur d’histocompatibilité (peptide-CMH, pCMH) portés par une cellules présentatrices d’antigène (CPAg), conduit à de nombreux remaniements du lymphocyte T. Il s’établit notamment à l’interface entre le lymphocyte T et la CPAg, une structure spécialisée qui est la synapse immunologique (ou synapse immune). La synapse est le siège d’événements de signalisation intenses où diverses molécules de signalisation nécessaires l’amplification et la diversification du signal provenant du TCR sont recrutées. Ces évènements de signalisation sont régulés par l’adaptateur transmembranaire LAT (« Linker for Activation of T cells ») qui est présent à la membrane plasmique ainsi que dans des compartiments intracellulaires. La fraction intracellulaire de LAT est recrutée à la synapse immune et il est proposé que ces compartiments vésiculaires participent à la signalisation lymphocytaire T. L’objectif de ce travail de thèse a été de déterminer les voies de trafic intracellulaire nécessaires au recrutement de la fraction intracellulaire de LAT à la synapse immunologique et de comprendre le rôle de ce transport dans l’activation et la réponse lymphocytaire T. Par des approches d’extinction de l’expression de différentes molécules de transport intracellulaires dans les cellules T Jurkat ou des lymphocytes T CD4+ primaires humains ou par l’utilisation de souris Knock-Out (KO), nous avons mis en évidence plusieurs voies de transport impliquées dans le transport de LAT. Nous avons ainsi mis en évidence que le recrutement de LAT à la synapse immunologique nécessite une voie de sécrétion dépendante de la protéine SNARE vésiculaire VAMP7. L’analyse plus avant du transport de LAT a par ailleurs permis de montrer que LAT est présente dans des compartiments de recyclage alors que VAMP7 est principalement localisée dans l’appareil de Golgi. L’étude de la petite GTPase Rab6 et de la protéine t-SNARE syntaxine-16 qui sont impliquées dans des voies de transport rétrograde entre les endosomes de recyclage et l’appareil de Golgi, a permis de dévoiler que cette voie de transport est requise dans le recrutement de LAT à la synapse immunologique, ainsi qu’à la réponse lymphocytaire T in vitro, ex vivo et in vivo. Enfin, le rôle de la protéine de transport intraflagellaire IFT20, qui a déjà été mis en cause dans le transport du TCR, a été analysé chez la souris et a également montré des défauts de recrutement de LAT à la synapse et dans l’activation lymphocytaire T ex vivo et in vivo. Nos résultats mettent ainsi en évidence que la régulation du transport intracellulaire dans les lymphocytes T joue un rôle crucial dans l’activation lymphocytaire T. Nous proposons ainsi un modèle dans lequel LAT est constitutivement internalisé depuis la membrane plasmique et poursuit une voie de recyclage dépendante de l’appareil de Golgi qui contient la machinerie de sécrétion associé à VAMP7. Cette voie de transport intracellulaire, conditionnerait la resécrétion polarisée de LAT à la synapse immunologique dans les conditions d’activation et une réponse lymphocytaire T robuste. / The immune response against a broad spectrum of pathogens or against tumor cells requires the CD4 + T lymphocytes activation. The triggering of T Cell Receptor (TCR) by peptide-MHC through antigen-presenting cells (APC) leads to numerous T-cell remodeling and the establishment of a specialized structure at the interface between the T lymphocyte and the APC: the immunological synapse. The synapse is the site of intense signaling events where various signaling molecules are recruited in order to amplify and diversify the signal initiated by the TCR. These signaling events are regulated by the transmembrane adapter LAT ("Linker for activation of T cells") which is present at the plasma membrane as well as in intracellular compartments. The intracellular fraction of LAT is recruited at the immune synapse and it is proposed that these vesicular compartments participate in T lymphocyte signaling. The objective of this thesis work was to determine the intracellular trafficking pathways required for the recruitment of the intracellular pool of LAT to the immunological synapse and understand the role of this transport in T cell activation and response. By silencing the expression of different intracellular transport molecules in Jurkat T cells or primary human CD4 + T lymphocytes, or by using Knock-Out (KO) mice, we have highlighted several trafficking pathways involved in the transport of LAT to the immune synapse. We have demonstrated that the recruitment of LAT to TCR activation sites requires a secretion pathway dependent on the vesicular SNARE protein VAMP7. Further analysis of the transport of LAT showed that LAT is present in recycling compartments whereas VAMP7 is mainly located in the Golgi apparatus. The study of the small GTPase Rab6 and the t-SNARE syntaxin-16 protein that are involved in the retrograde transport pathways between the recycling endosomes and the Golgi apparatus, demonstrated that this route of transport is required for the recruitment of LAT to the immunological synapse and for T lymphocyte response in vitro, ex vivo and in vivo as well. Finally, the role of intraflagellar transport protein IFT20, which has already been implicated in the transport of TCR, was analyzed in mice and also showed defects in LAT recruitment to synapse and T lymphocyte activation ex vivo and in vivo. Our results thus show that the regulation of intracellular transport plays a crucial role in T lymphocyte activation. We thus propose a model in which LAT is constitutively internalized from the plasma membrane and pursues a Golgi-dependent recycling pathway that contains the secretion machinery associated with VAMP7. This intracellular transport pathway would thus allow the polarized LAT re-secretion to the immunological synapse under activation conditions and a robust T lymphocyte response.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 5 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2007. / Härtill 3 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 6 uppsatser. - Titel från omslaget.